Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SpringWorks Therapeutics: Q1 Earnings Insights

SpringWorks Therapeutics (NASDAQ:SWTX) reported its Q1 earnings results on Wednesday, May 3, 2023 at 06:30 AM. Here’s what…
byBenzinga Insights
May 3, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

SpringWorks Therapeutics (NASDAQ:SWTX) reported its Q1 earnings results on Wednesday, May 3, 2023 at 06:30 AM.

Here’s what investors need to know about the announcement.

Earnings

SpringWorks Therapeutics beat estimated earnings by 5.6%, reporting an EPS of $-1.18 versus an estimate of $-1.25.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 4.04% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for SpringWorks Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Better Choice Stock Is Climbing Higher Today

By Erica Kollmann
April 16, 12:49 PM
Better Choice's board of directors has authorized a stock repurchase program under which the company can repurchase up to $5 million of the currently outstanding shares of its common stock, until Dec. 31, 2024. The company reported its fourth-quarter financial results Friday with losses of $6.51 per share and quarterly sales of $5.702 million.

BTTR